Literature DB >> 25260277

Clinical significance and determinants of the universal definition of perioperative bleeding classification in patients undergoing coronary artery bypass surgery.

Eeva-Maija Kinnunen1, Tatu Juvonen1, Kari Eino Juhani Airaksinen2, Jouni Heikkinen1, Ulla Kettunen1, Giovanni Mariscalco3, Fausto Biancari4.   

Abstract

OBJECTIVES: We evaluated the clinical significance and identified the predictors of the universal definition of perioperative bleeding (UDPB) classes in patients undergoing isolated coronary artery bypass grafting (CABG).
METHODS: Data on antithrombotic medication, perioperative bleeding, blood transfusion, and adverse events were available for 2764 patients who had undergone isolated CABG.
RESULTS: The Papworth risk score correlated significantly with the UDPB classes (rate of UDPB class 3-4 and Papworth risk score of 0, 12.1%; 1, 23.9%; 2, 37.5%; and 3, 45.0%; P<.0001). Ordinal regression showed that increased age, female sex, low body mass index, low estimated glomerular filtration rate, low hemoglobin, dialysis, urgent or emergency operation, critical status, on-pump surgery, potent antiplatelet drug pause of <5 days, and warfarin pause of <2 days were independent predictors of high UDPB classes. These risk factors also predicted UDPB classes 3-4 in logistic regression analysis. Increasing UDPB classes were associated with an increased risk of in-hospital mortality (P=.002), stroke (P=.023), low cardiac output (P<.0001), prolonged use of inotropes (P<.0001), renal replacement therapy (P<.0001), length of stay in the intensive care unit (P<.0001), and late mortality (P<.0001) as assessed by multilevel propensity score-adjusted analysis. Similar findings were observed in the propensity score-adjusted analysis for the most severe grades of perioperative bleeding (ie, UDPB class 3-4).
CONCLUSIONS: High UDPB classes were associated with significantly poorer immediate and late outcomes. The UDPB classification seems to be a valuable research tool to estimate the severity of bleeding and its prognostic impact affect after coronary surgery.
Copyright © 2014 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25260277     DOI: 10.1016/j.jtcvs.2014.07.040

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

1.  Association between Intra-Circuit Activated Clotting Time and Incidence of Bleeding Complications during Continuous Renal Replacement Therapy using Nafamostat Mesilate: a Retrospective Pilot Observational Study.

Authors:  Yuji Miyatake; Shohei Makino; Kenta Kubota; Moritoki Egi; Satoshi Mizobuchi
Journal:  Kobe J Med Sci       Date:  2017-08-30

2.  Impact of major bleeding on the risk of acute kidney injury in patients undergoing off-pump coronary artery bypass grafting.

Authors:  Wei Liu; Ziwei Xi; Chengxiong Gu; Ran Dong; Jumana AlHelal; Zhenxian Yan
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

3.  Use of a flowable haemostat versus an oxidised regenerated cellulose agent in primary elective cardiac surgery: economic impact from a UK healthcare perspective.

Authors:  Mayur R Joshi; Jacqueline Latham; Gabriel Okorogheye
Journal:  J Cardiothorac Surg       Date:  2017-11-29       Impact factor: 1.637

4.  The Prognostic Significance of Different Bleeding Classifications in off-pump coronary artery bypass grafting.

Authors:  Ziwei Xi; Yanan Gao; Zhenxian Yan; Yu-Jie Zhou; Wei Liu
Journal:  BMC Cardiovasc Disord       Date:  2020-01-10       Impact factor: 2.298

5.  Early postoperative bleeding impacts long-term survival following first-time on-pump coronary artery bypass grafting.

Authors:  Thomas Senage; Caroline Gerrard; Narain Moorjani; David P Jenkins; Jason M Ali
Journal:  J Thorac Dis       Date:  2021-10       Impact factor: 2.895

6.  Bleeding Classifications in CABG: perspective on Prognostic Performance.

Authors:  Rohan Magoon; Souvik Dey; Jasvinder Kaur Kohli; Ramesh Kashav
Journal:  Braz J Cardiovasc Surg       Date:  2020-06-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.